Deborah Ashby

Featured in: Favicon

nature.com Favicon

medscape.com Favicon

science.org Favicon

thelancet.com Favicon

my-indiana-home.com

Articles

SARS-CoV-2 rapid antibody test results and subsequent risk of hospitalisation and death in 361,801 people - Nature Communications

Aug 16, 2023 | nature.com | Bethan Davies |Christina J Atchison |Wendy Barclay |Deborah Ashby |Ara Darzi |Graham Cooke | +3 more

AbstractThe value of SARS-CoV-2 lateral flow immunoassay (LFIA) tests for estimating individual disease risk is unclear. The REACT-2 study in England, UK, obtained self-administered SARS-CoV-2 LFIA test results from 361,801 adults in January-May 2021. Here, we link to routine data on subsequent hospitalisation (to September 2021), and death (to December 2021).

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →